A Safety, Tolerability and Efficacy Study in Chronic Obstructive Pulmonary Disease (COPD) Patients With QBM076.

NCT01972776 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

48

Enrollment

INDUSTRY

Sponsor class

Stopped Part 1 was completed. Part 2 was terminated for safety reasons.

Conditions

COPD

Interventions

DRUG: QBM076
DRUG: Placebo

Sponsor

Novartis Pharmaceuticals